Group One Trading
CLGN icon

Group One Trading’s CollPlant Biotechnologies CLGN Stock Holding History

Group One Trading’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-140
Closed -$749 – 7675
2026
Q1 		$749 Sell
140
-350
-71% -$3.53K ﹤0.01% 7261
2025
Q4 		$6.91K Sell
490
-10
-2% -$205 ﹤0.01% 7025
2025
Q3 		$13.4K Buy
+500
New +$11.9K ﹤0.01% 6989

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $243M AUM 8.27% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Group One Trading's CLGN Position: Q2 2026 in Review

Group One Trading sold out of CollPlant Biotechnologies (CLGN) in Q2 2026, closing a stake of 140 shares — an estimated $749 sold.

Group One Trading first reported a position in CLGN in Q3 2025 and held it in 3 quarters. The position peaked at $13.4K in Q3 2025. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • Group One Trading reported no remaining CollPlant Biotechnologies position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 140 CollPlant Biotechnologies shares in Q2 2026, an estimated $749.
  • Group One Trading first reported a position in CollPlant Biotechnologies in Q3 2025 and held it in 3 quarters.
  • Group One Trading's CollPlant Biotechnologies position peaked at $13.4K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.